Estradiol as an antioxidant: incompatible with its physiological concentrations and function

• Published in: Journal of lipid research 1998-11, Vol.39 (11), p.2111-2118
• Main Authors: Santanam, N, Shern-Brewer, R, McClatchey, R, Castellano, P Z, Murphy, A A, Voelkel, S, Parthasarathy, S
• Format: Article
• Language: English
• Subjects: Adult; atherosclerosis; Copper - metabolism; coronary artery disease; Estradiol - analogs & derivatives; Estradiol - physiology; Female; Fertilization in Vitro; Follicular Phase; Humans; lipid peroxidation; Lipoproteins, LDL - blood; menopause; Menopause - physiology; Menstrual Cycle - physiology; Middle Aged; myeloperoxidase; Ovulation Induction; Oxidation-Reduction; oxidized low-density lipoprotein; Peroxidase - metabolism; Peroxidases - metabolism
• ISSN: 0022-2275
• DOI: 10.1016/S0022-2275(20)32465-2

Estradiol has been documented to inhibit the oxidation of low density lipoprotein (LDL). We show that physiological concentrations of estradiol do not inhibit the oxidation of LDL by copper. LDL samples isolated from a) premenopausal and postmenopausal women and from b) women at different time periods during their menstrual cycle, who differ vastly in plasma estradiol levels, were also oxidized at the same rates by copper. In contrast, LDL samples isolated from c) women who were hyperstimulated during in vitro fertilization (IVF), with estradiol concentrations above 2000 pg/ml, were resistant to oxidation by copper. However, these LDL samples were also oxidized at a higher rate by peroxidases. More importantly, subjects with high estradiol levels also showed an increase in myeloperoxidase (MPO) protein in the plasma. Based on these results, we conclude that at physiologic concentrations, it is unlikely that estradiol could act as an antioxidant. In fact, the ability of estradiol to induce MPO and become a prooxidant might instead suggest that MPO-mediated oxidative clearance of LDL from plasma by liver might favorably influence the outcome of atherosclerosis.